Orchid Pharma gets US FDA nod for naratriptan tabs

The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid Pharma) has received approval from the US Food and Drug Administration (US FDA) for its ANDA (Abbreviated New Drug Application) for naratriptan tablets in the 1 mg and 2.5 mg strengths.

Naratriptan tablets are the generic equivalent of GSK’s Amerge tablets.